|
USP9X expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.40189999999307E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.4034000001858E-07 |
| Normal-vs-Stage2 |
1.110770E-01 |
| Normal-vs-Stage3 |
5.902800E-01 |
| Normal-vs-Stage4 |
2.738400E-01 |
| Stage1-vs-Stage2 |
2.916200E-01 |
| Stage1-vs-Stage3 |
6.550200E-02 |
| Stage1-vs-Stage4 |
7.610200E-01 |
| Stage2-vs-Stage3 |
4.546600E-01 |
| Stage2-vs-Stage4 |
8.313000E-01 |
| Stage3-vs-Stage4 |
4.583000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.11520000004128E-06 |
| Normal-vs-AfricanAmerican |
2.260000E-02 |
| Normal-vs-Asian |
8.259000E-01 |
| Caucasian-vs-AfricanAmerican |
2.804800E-01 |
| Caucasian-vs-Asian |
2.723600E-01 |
| AfricanAmerican-vs-Asian |
5.694400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66540004009619E-09 |
| Normal-vs-Female |
2.620000E-01 |
| Male-vs-Female |
7.63759999689029E-08 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.569510E-02 |
| Normal-vs-Extreme_Weight |
4.53439952252666E-10 |
| Normal-vs-Obese |
6.970300E-02 |
| Normal-vs-Extreme_Obese |
9.83119999999893E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.304100E-02 |
| Normal_Weight-vs-Obese |
4.524200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.866210E-01 |
| Extreme_Weight-vs-Obese |
1.382140E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.892000E-01 |
| Obese-vs-Extreme_Obese |
3.942300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.941600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.234100E-02 |
| Normal-vs-Age(61-80Yrs) |
6.76650002695567E-09 |
| Normal-vs-Age(81-100Yrs) |
2.12219999999874E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.470170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.685870E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.305600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.422580E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.464080E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.631600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.86120000522649E-08 |
| Normal-VS-Type2 PRCC |
5.944200E-03 |
| Normal-VS-KIRP CIMP |
6.380600E-01 |
| Normal-VS-Unclassified PRCC |
7.517600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.783900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.131900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.504200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.699500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.064400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.746600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.445000E-04 |
| Normal-vs-N1 |
6.268000E-01 |
| Normal-vs-N2 |
3.918100E-02 |
| N0-vs-N1 |
2.844200E-02 |
| N0-vs-N2 |
9.578000E-01 |
| N1-vs-N2 |
3.451000E-01 |
|
|
